RT Journal Article SR Electronic T1 Antimalarial Drug Resistance in Plasmodium falciparum from Tak Province, Thailand (1998-2001): A TaqMan Array Card Study JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2024.05.29.24308164 DO 10.1101/2024.05.29.24308164 A1 Thaloengsok, Sasikanya A1 Chaisatit, Chaiyaporn A1 Saingam, Piyaporn A1 Lertsethtakarn, Paphavee A1 Spring, Michele A1 Sabaithip, Sriwichai A1 Pholwat, Suporn A1 Guler, Jennifer L A1 Houpt, Eric A1 Vesely, Brian YR 2024 UL http://medrxiv.org/content/early/2024/05/31/2024.05.29.24308164.abstract AB Despite declining malaria cases in Thailand, surveillance in endemic areas is crucial. Retrospectively analyzing samples from Tak province, Thailand, we found prevalent drugresistant Plasmodium falciparum, particularly to mefloquine and sulfadoxine/pyrimethamine. Notably, mutations indicating resistance to artemisinin were detected at low frequencies, suggesting evolving resistance. These findings stress the need for continuous surveillance to guide control strategies and prevent outbreaks, even with decreasing cases, to sustain malaria elimination efforts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the United States Department of Defense Armed Forces Health Surveillance Division-Global Emerging Infectious Disease Surveillance Branch (AFHSD-GEIS): P0005_19_AF. The funding source had no role in the analysis or interpretation of data, preparation of the manuscript or the decision to publish.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All participants provided written informed consent and samples were collected under approval the Ethical Review Committee for Research in Human Subjects, Ministry of Public Health (MoPH EC) and Walter Reed Army Institute of Research Institutional Review board under WRAIR #2902I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors